Home care at a crossroads: VA cuts, new rules, and big players reshape the industry

By early May 2026, the VA's steep reimbursement cuts—43% in rural Texas and 19% in New Mexico—have placed significant financial and operational strain on home care providers like Live Well Home Care, who struggle to retain caregivers and ensure timely services. Providers and advocacy groups have vocally criticized the VA for implementing these cuts without consultation, warning that such short-sighted savings risk escalating overall costs by pushing veterans into more expensive, higher-acuity care settings.

Despite these challenges, some providers like Synergy HomeCare have managed to grow their market share, highlighting a varied impact across the sector. Meanwhile, active lobbying efforts by providers and advocacy groups aim to persuade the VA and lawmakers to reconsider the cuts and establish more reasonable reimbursement rates that support sustainable home care for veterans.

By June 2026, home-based care leaders describe the reimbursement landscape as a 'death by 1,000 cuts,' with incremental reductions and inconsistent payment rates across Medicare, Medicaid, VA, and private payers cumulatively squeezing financial viability. Joe Shannon of HomeCentris Healthcare captures this pressure, noting stagnation on Medicare Advantage rates alongside cuts elsewhere, prompting providers to diversify their payer mixes and forge local partnerships to survive.

In response to these ongoing reimbursement pressures, providers are strategically expanding their payer networks and employing data-driven advocacy to improve reimbursement conditions. This shift towards leveraging analytics and broadening payer relationships reflects a proactive adaptation to a fragmented and tightening funding environment.

By early 2026, CMS unveiled a transformative set of 23 mandatory HCBS quality measures slated for 2028, pivoting away from traditional operational metrics toward person-centered outcomes that prioritize individual goals and community participation. This shift challenges providers, especially smaller ones, with heightened reporting demands whose impact will hinge on state-level implementation, technical support, and reimbursement strategies. As Bill Hanna of ATI Advisory emphasizes, while these measures do not immediately alter payment structures, they lay critical groundwork for future value-based care models, enabling states and managed care organizations to eventually tie reimbursement to performance.

Providers are encouraged to approach the new CMS quality measures not merely as compliance hurdles but as strategic opportunities to showcase their value in a landscape marked by significant state-by-state variation. This dual perspective allows home care organizations to proactively adapt to evolving regulatory expectations while positioning themselves advantageously for the anticipated shift toward value-based reimbursement.

By early 2026, the home care sector is witnessing a strategic pivot as major players like BrightSpring Health Services, Pennant Group, and Addus leverage mergers and acquisitions to navigate the intensified federal crackdown on fraud, waste, and abuse. BrightSpring and Pennant remain focused on integrating the Amedisys assets acquired the previous year, consolidating their market positions, while Addus signals readiness for bold new deals, positioning itself as a key consolidator. This regulatory pressure, rather than stifling growth, is catalyzing market consolidation where providers with sufficient scale view compliance challenges as opportunities to expand and capitalize on shifting dynamics.

By early 2026, the home care market is grappling with a widening gap between demand and provider availability, as Medicaid home care recipients per provider rose from 59 in 2019 to 66 in 2023, signaling mounting pressure on service capacity and access. This strain is underscored by the dominance of personal care services, which make up 62.7% of home care claims, reflecting their essential role in delivering flexible, person-centered care amidst growing and diverse needs. Together, these trends highlight a market stretched thin yet reliant on adaptable service models to meet escalating demand.

Looking ahead, the One Big Beautiful Bill Act (OBBBA) introduces a significant policy shift projected to reduce home care enrollment by approximately 300,000 by 2034, primarily through mechanisms like frequent eligibility redeterminations and new cost-sharing requirements. While this reduction may alleviate some pressure on providers, it raises concerns about potential barriers to access and the capacity of the market to serve vulnerable populations effectively under evolving regulatory frameworks.

By early 2026, Addus HomeCare demonstrated resilient financial performance despite external challenges such as weather disruptions that caused it to miss revenue expectations in Q1. The company still achieved a 7.7% year-over-year revenue growth and beat adjusted EPS and EBITDA estimates while maintaining stable operating margins, underscoring operational efficiency gains partly driven by technology deployments like the caregiver app in Texas.

Addus is strategically navigating the regulatory landscape shaped by the CMS moratorium by focusing on acquisitions and organic growth rather than de novo home health expansion, which the moratorium restricts. CEO Dirk Allison emphasized that this approach, combined with a robust compliance program that enhances payer negotiations and aligns with CMS’s anti-fraud efforts, insulates the company’s growth trajectory and valuation from moratorium impacts.

The company’s acquisition strategy remains aggressive, particularly in personal care services and Indiana markets, where improved state reimbursement rates and integration of recent acquisitions are expected to drive future revenue growth. Despite a softening in sector valuations with current acquisition multiples dipping below double digits, Addus continues to pursue sizable deals in personal care segments unaffected by the CMS moratorium, signaling a deliberate pivot to areas with favorable regulatory and market dynamics.

Addus is positioning itself for above-average growth in its personal care and hospice segments, aligning its strategic focus with evolving market demands and regulatory environments. This shift reflects a broader industry trend where providers emphasize service lines less constrained by regulatory moratoriums and more receptive to technology-enabled efficiencies and acquisition-driven scale.